Custom Search

News

Thursday 01 February 2001

Respiratory and cardiovascular effects of WP-934 in guinea pigs.

By: Hashimoto T, Toyoda Y, Taniguchi T, Kitazawa Y.

J Ocul Pharmacol Ther 2001 Feb;17(1):75-82

WP-934 is a newly developed reversible thermo-setting in situ gelling ophthalmic solution containing timolol. We investigated the effects of WP-934 on the respiratory and cardiovascular systems in guinea pigs and compared them with those of the conventional ophthalmic solution of timolol. At 30 min after instillation of timolol 0.5%, the airway responsiveness to histamine was 4 times higher, and that to acetylcholine was 2.5 times higher, than that before instillation. At 30 min after instillation of WP-934 0.5%, in contrast, the increase in responsiveness to each drug was about half that seen with the conventional solution. Topical instillation of timolol 0.5% weakened the effects of salbutamol and aminophylline on bronchodilatation, while that of WP-934 0.5% had no effect on aminophylline-induced bronchodilatation and a weaker effect on salbutamol-induced bronchodilatation. Topical instillation of timolol 0.5% and WP-934 0.5% failed to show a significant effect on blood pressure but caused a 10 to 20% decrease in heart rate for at least 120 min after instillation. WP-934 appears to have less respiratory adverse effects than timolol, mainly due to its longer retention on the ocular surface and a consequent decrease in systemic absorption.

Use of this site is subject to the following terms of use